Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00971 |
| Species: | Homo sapiens |
| Position : | chr16:55500100-55502100 |
| Year: | 2015 |
| Title: | Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | bladder carcinoma |
| PMID: | 26679052 |
| MONDO: | MONDO:0005094 |
| Tissue: | Bladder |
| Tissue Ontology ID: | UBERON:0001255 |
| Cell Source: | 5637 |
| CVCL ID: | CVCL_0126 |
| Cell Type: | bladder carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR, Western blot |
| Target gene : | MMP2 |
| TF name : | C-FOS |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|